While we try to keep things accurate, this content is part of an ongoing experiment and may not always be reliable.
Please double-check important details — we’re not responsible for how the information is used.
Diabetes
“Unraveling the Secrets of Focal Cortical Dysplasia: How Disturbed Signaling Pathways Could Promote Epileptic Seizures”
Focal cortical dysplasia (FCD) type 2 is a congenital malformation of the cerebral cortex that is often associated with difficult-to-treat epilepsy. In the affected areas, nerve cells and their layer structures are arranged in an atypical manner, which often makes drug therapy more difficult. A research team has now found evidence of profound changes in the dopamine system in FCD type 2.

Cancer
A Breakthrough in Inflammation Control: Scientists Discover ‘Off Switch’ Enzyme to Combat Heart Disease and Diabetes
Researchers at UT Arlington have discovered a key enzyme, IDO1, that when blocked, helps immune cells regain their ability to properly process cholesterol—something that breaks down during inflammation. This breakthrough could offer a powerful new way to fight heart disease, diabetes, cancer, and more. By “turning off” this enzyme, the team restored cholesterol absorption in macrophages, potentially stopping disease at the source. Even more promising, they found a second enzyme, NOS, that makes things worse—raising hopes that targeting both could pave the way for transformative treatments for millions suffering from inflammation-driven conditions.
Diabetes
The Ancient Longevity Switch: How Morning Coffee Could Be Slowing Down Your Ageing Process
Caffeine appears to do more than perk you up—it activates AMPK, a key cellular fuel sensor that helps cells cope with stress and energy shortages. This could explain why coffee is linked to better health and longer life.
Alzheimer's
Groundbreaking Study Suggests Link Between Semaglutide and Lower Dementia Risk in Type 2 Diabetes Patients
A blockbuster diabetes and weight-loss drug might be doing more than controlling blood sugar—it could also be protecting the brain. Researchers at Case Western Reserve University found that people with type 2 diabetes who took semaglutide (the active ingredient in Ozempic and Wegovy) had a significantly lower risk of developing dementia. The benefit was especially strong in women and older adults.
-
Detectors3 months ago
A New Horizon for Vision: How Gold Nanoparticles May Restore People’s Sight
-
Earth & Climate4 months ago
Retiring Abroad Can Be Lonely Business
-
Cancer4 months ago
Revolutionizing Quantum Communication: Direct Connections Between Multiple Processors
-
Agriculture and Food4 months ago
“A Sustainable Solution: Researchers Create Hybrid Cheese with 25% Pea Protein”
-
Diseases and Conditions4 months ago
Reducing Falls Among Elderly Women with Polypharmacy through Exercise Intervention
-
Chemistry3 months ago
“Unveiling Hidden Patterns: A New Twist on Interference Phenomena”
-
Albert Einstein4 months ago
Harnessing Water Waves: A Breakthrough in Controlling Floating Objects
-
Earth & Climate4 months ago
Household Electricity Three Times More Expensive Than Upcoming ‘Eco-Friendly’ Aviation E-Fuels, Study Reveals